Quick follow up thread on the #coughsyrup tragedy in The Gambia.
The official line seems to be that we dont have to worry about adulterated cough syrup because the company is making this product just for its overseas customers.
Lets see if this holds water, shall we?
1/n
2/n Here is a snapshot of the company's catalog showing the line of cough syrups it manufactures:
3/n While they may not selling cough syrup under the names they exported it to the Gambia, they are likely selling cough-syrup in India.
Here are some of their products – we found domestic trademark registrations for Kof-Total which likely means they are selling it in India:
4/n
5/n
6/n
7/n
Here is the trademark for Macold:
7/n
8/n
What do you think about the claim made by him 👇👇 now?
9/n More importantly, why do you think the administration put out a press release giving credence to this argument?
Shouldnt you ask?
The reason we should is because it has happened before.
Stay with me please.
10/n
Some eight months after the first wave of deaths due to DEG poisoning in Jammu in 2020, a two year old child, Radhika succumbed to the same cause after taking a syrup manufactured by Digital Vision sold under a different name.
11/n @PriyankaPulla did a heart-wrenching report on this incident here:
Why is the CDSCO not initiating a nation-wide recall for all syrups made by Maiden Pharma is a question that we need to ask?
12/n
Read about our dysfunctional drug regulatory system and how broken the whole process is which leads to deaths of young children like Radhika every day in the #truthpill
How did this firm generate six-month real time accelerated stability data when the inspection found no samples of the product in the stability chamber?
One of key requirements for product registration is for the manufacturer to show that its formulation is stable under
We wanted to provide our readers direct access to our research because there is only so much we could put into our book. To that end, we are announcing the launch of an accompanying website for #thetruthpill where all our research is curated.
All primary research for our book is available to journalists, reporters and anyone who is interested in studying this topic further can access it here:
3/n
There are three key questions that need answers:
1.What is the track record of this company in making quality products for patients?
2.What role do national and state regulators play in ensuring quality of global medicinal products?
3.Does the COPP certification process
During the peak pandemic period, batches of a drug called Remdesivir manufactured by a Gujarat based pharma company were found to contain bacterial endotoxins which when administered to patients manifested in severe adverse
3/n events. Endotoxins are not supposed to be present in injectibles, the way to make sure your drugs are not contaminated is to run a series of tests prescribed in the Indian Pharmacopiea before you ship them the market. The Pharmacopiea sets the standards and tells us what
Over the last couple of days, scandalous news of the arrest of a Joint Drug Controller in @CDSCO_INDIA_INF has made waves. While much of the reporting is perfunctory until now, it helps to peel the onion and see how far the stench
2/n
of corruption pervades the unholy nexus between the pharmaceutical industry and the DCGI’s office.
Lets start with a few facts, shall we:
A.“CBI officers claimed Bioinnovat Research Services Private Limited had been asked to get regulatory clearance for the Biocon
3/n
product. Bioinnovate, in turn, engaged Synergy Network to get the work done, the officers claimed.” indianexpress.com/article/india/…
Last week, we sent a petition to the Minister of @MoHFW_INDIA asking for the Clinical Trial Registry of India to be fixed once and for all. Here it is: